相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phosphorylation of protein phosphatase 1 by cyclin-dependent protein kinase 5 during nerve growth factor-induced PC12 cell differentiation
Tong Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Glycogen synthase kinase 3β phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism
T Li et al.
BIOCHEMISTRY (2006)
Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3β
T Li et al.
BIOCHEMISTRY (2006)
Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology
IF Bronner et al.
BRAIN (2005)
Tau pathology in Alzheimer disease and other tauopathies
K Iqbal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)
Role of tau protein in both physiological and pathological conditions
J Avila et al.
PHYSIOLOGICAL REVIEWS (2004)
Mutant (R406W) human tau is hyperphosphorylated and does not efficiently bind microtubules in a neuronal cortical cell model
PK Krishnamurthy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Promotion of hyperphosphorylation by frontotemporal dementia tau mutations
AD Alonso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
14-3-3 binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3β in the brain
ZF Yuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum
M Mesulam et al.
ANNALS OF NEUROLOGY (2004)
Glycogen synthase kinase-3,β is complexed with tau protein in brain microtubules
W Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Neuronal Cdc2-like protein kinase (Cdk5/p25) is associated with protein phosphatase 1 and phosphorylates inhibitor-2
A Agarwal-Mawal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3β identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes
JW Connell et al.
FEBS LETTERS (2001)
Tau proteins with frontotemporal dementia-17 mutations have both altered expression levels and phosphorylation profiles in differentiated neuroblastoma cells
TGA Mack et al.
NEUROSCIENCE (2001)
Neurodegenerative tauopathies
VMY Lee et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells
V Vogelsberg-Ragaglia et al.
MOLECULAR BIOLOGY OF THE CELL (2000)
14-3-3ζ is an effector of tau protein phosphorylation
M Hashiguchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Interaction of neuronal Cdc2-like protein kinase with microtubule-associated protein tau
K Sobue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The FTDP-17-linked mutation R406W abolishes the interaction of phosphorylated tau with microtubules
M Pérez et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Abnormal tau-containing filaments in neurodegenerative diseases
RA Crowther et al.
JOURNAL OF STRUCTURAL BIOLOGY (2000)
Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene
K Arima et al.
NEUROLOGY (2000)
分享论文
